An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in Serum
Authors:
- 1 January 1980
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 3 (5) , 637-644
Abstract
An HPLC method using reverse phase chromatography is presented for the quantitative determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) amino] ethyl] amino] 9,10 - anthracenedione in serum and urine at levels which are expected to be found in clinical trials of this drug.Keywords
This publication has 4 references indexed in Scilit:
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinonesJournal of Medicinal Chemistry, 1978
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976
- Adriamycin1976